NUCLEOSIDE COMPOUNDS AND THEIR USE FOR TREATING CANCER AND DISEASES ASSOCIATED WITH SOMATIC MUTATIONS

Details for Australian Patent Application No. 2003254158 (hide)

Owner PTC THERAPEUTICS, INC.

Inventors WILDE, Richard, G.; KENNEDY, Paul, D.; ALMSTEAD, Neil, G.; WELCH, Ellen, M.; TAKASUGI, James, J.; FRIESEN, Westley, J.

Pub. Number AU-A-2003254158

PCT Number PCT/US03/23184

PCT Pub. Number WO2004/009609

Priority 60/398,334 24.07.02 US; 10/625,059 22.07.03 US

Filing date 23 July 2003

Wipo publication date 9 February 2004

International Classifications

C07H 019/00 Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 60/398,334 24.07.02 US; 10/625,059 22.07.03 US

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2003254158

5 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003254159-Use of digoxin immune Fab for the regulation of sodium/potassium ATPase activity in preeclamptic and eclamptic patients

2003254157-ACETYLAMINO BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE